InvestorsHub Logo

jour_trader

11/07/22 8:55 AM

#375275 RE: jbdiver #375273

Lannett did fantastic with IR. ER on other hand was pitiful. Company has been able to continue to invest in pipeline and hopefully is starting to move before another round of Covid hits studies, balance sheet is shored up to help weather upcoming transition away from Lannett and we have new chief of sales and CFO. We have some major speed bumps ahead, but think the ship will sail through these rough waters. Seat belts will need to be buckled as there will be some rough spots for sure.

Sctrben

11/07/22 12:09 PM

#375286 RE: jbdiver #375273

Sungen started off gangbuster, had a pipeline of promising antibiotics that were lined up and progressing, and then, their issues became ours w enter Praxgen. Thankfully the Adderall line got far enough along to get our heads above water to breathe at CFP, and now find that at another challenging crossroad due to another partner LCI in-house directions/decisions.

But yeah, we have a well documented history of partner flops and unfortunate mishaps along with some worldly pandemics/events sprinkled in there for fun.

We’ve somehow continued to stay alive, surviving to fight another day, we’ve looked possible bk as a true reality in the face and got through it a few times with something coming along to save us.

I’m grateful to still have an investment here and believe there’s a Good Run ahead with plenty of potentials to go/grow on…